Abstract 5320: Transcatheter Aortic Valve Replacement as a Bridge to Simultaneous Liver and Kidney Transplantation in Severe Aortic Stenosis and Cirrhosis
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.5320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Aarnav Goyal und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Severe aortic stenosis (AS) is associated with significant perioperative risk in patients undergoing solid organ transplantation. In patients with decompensated cirrhosis, surgical aortic valve replacement (SAVR) carries high operative morbidity and mortality, frequently precluding transplant candidacy. While transcatheter aortic valve replacement (TAVR) has emerged as a bridging strategy to isolated liver or kidney transplantation in high-risk patients, its use as a bridge specifically to simultaneous liver-kidney (SLK) transplantation remains rarely reported. Case Presentation: A 71-year-old man with decompensated NASH cirrhosis (MELD-Na 20) complicated by esophageal and rectal varices, hepatic encephalopathy, severe thrombocytopenia (platelets ~20х10 9 /L), chronic kidney disease, and coronary artery disease presented for transplant evaluation. Initial echocardiography suggested moderate-to-severe AS (mean gradient: 36 mmHg; aortic valve area index [AVAi]: 0.45 cm 2 /m 2 ); repeat echocardiographic and invasive hemodynamic assessment during transplant evaluation confirmed severe AS (mean gradient: 40 mmHg; peak velocity: 3.89 m/s; AVAi: 0.53 cm 2 /m 2 ). Given advanced cirrhosis and multiple comorbidities, he was deemed unsuitable for SAVR by cardiothoracic surgery, making him ineligible for transplantation. After multidisciplinary evaluation, transfemoral TAVR was selected as bridging therapy. Intervention and Outcomes: Given severe thrombocytopenia, the patient received packed red blood cells, platelets, and fresh frozen plasma prior to the procedure. Transfemoral TAVR with a 29-mm Edwards SAPIEN 3 Resilia valve was performed without intraprocedural complications. Follow-up echocardiography showed marked improvement in valve hemodynamics (mean gradient: 6 mmHg; peak velocity: 1.72 m/s; AVAi: 1.24 cm 2 /m 2 ). Prior to transplantation, he was hospitalized for hepatorenal syndrome requiring initiation of hemodialysis. Three months post-TAVR, SLK transplantation was performed, complicated intraoperatively only by transient atrial fibrillation with rapid ventricular response. Longitudinal tracking confirmed durable valve function, with a transient, self-resolving gradient increase to 13 mmHg at one month post-transplant, normalizing to 8 mmHg at one year (AVAi: 1.39 cm 2 /m 2 ), alongside excellent dual-graft function with normalized bilirubin and creatinine (1.36 mg/dL) without rejection.
Conclusion
This case demonstrates that TAVR can safely restore SLK transplantation eligibility in patients with severe AS and prohibitive surgical risk, with durable valve and dual-graft function confirmed at one year. Careful multidisciplinary coordination may permit successful SLK transplantation in select patients otherwise considered unsuitable surgical candidates.
Zitieren
APA
Goyal, A., Sharma, A., Derbas, L., Stern, D., Dhar, G., & Jolly, N. (2026). Abstract 5320: Transcatheter Aortic Valve Replacement as a Bridge to Simultaneous Liver and Kidney Transplantation in Severe Aortic Stenosis and Cirrhosis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.5320
Vancouver
Goyal A, Sharma A, Derbas L, Stern D, Dhar G, Jolly N. Abstract 5320: Transcatheter Aortic Valve Replacement as a Bridge to Simultaneous Liver and Kidney Transplantation in Severe Aortic Stenosis and Cirrhosis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.5320
BibTeX
@article{Goyal2026,
author = {Goyal, Aarnav and Sharma, Aarshi and Derbas, Laith and Stern, David and Dhar, Gaurav and Jolly, Neeraj},
title = {Abstract 5320: Transcatheter Aortic Valve Replacement as a Bridge to Simultaneous Liver and Kidney Transplantation in Severe Aortic Stenosis and Cirrhosis},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.5320}
}
EUVIMED